Exhibit 16.1
\
June 15, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Gentlemen:
We have read Item 4.01 and 4.02 of Form 8-K dated June 15, 2012 of American Oriental Bioengineering, Inc. (the “Company”) and are in agreement with the statements contained in (i) the first and second paragraphs of Item 4.01(a) and (ii) Item 4.02 therein. We have no basis to agree or disagree with other statements of the Company contained in Item 4.01.
Your faithfully.
/s/ Ernst & Young Hua Ming
Ernst & Young Hua Ming
Shanghai Branch